{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:48:18Z","timestamp":1773661698245,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.yebeh.2004.08.002","type":"journal-article","created":{"date-parts":[[2004,10,5]],"date-time":"2004-10-05T11:36:57Z","timestamp":1096976217000},"page":"802-803","source":"Crossref","is-referenced-by-count":12,"title":["Phenobarbital: a drug for the 21st century?"],"prefix":"10.1016","volume":"5","author":[{"given":"Martin J.","family":"Brodie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.yebeh.2004.08.002_bib1","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1046\/j.1528-1157.43.s.6.13.x","article-title":"The treatment gap","volume":"43","author":"Kale","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2004.08.002_bib2","unstructured":"International drug price indicator guide. Management Science for Health 2003. Available from: http:\/\/erc.msh.org. Accessed 26 June 2004"},{"key":"10.1016\/j.yebeh.2004.08.002_bib3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archpedi.153.12.1267","article-title":"Treatment of newly diagnosed pediatric epilepsy: a community-based study","volume":"153","author":"Berg","year":"1999","journal-title":"Arch Paediatr Adolesc Med"},{"key":"10.1016\/j.yebeh.2004.08.002_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1059-1311(98)80013-7","article-title":"Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey","volume":"7","author":"Baldy-Moulinier","year":"1998","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2004.08.002_bib5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1212\/WNL.49.4.991","article-title":"Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy","volume":"49","author":"Musicco","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2004.08.002_bib6","first-page":"528","article-title":"Phenobarbital and other barbiturates: adverse effects","author":"Baulac","year":"2002"},{"key":"10.1016\/j.yebeh.2004.08.002_bib7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.0013-9580.2004.12704.x","article-title":"Phenobarbital for the treatment of epilepsy in the 21st century: a critical review","volume":"45","author":"Kwan","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2004.08.002_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondary tonic-clonic seizures","volume":"313","author":"Mattson","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2004.08.002_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(96)90074-4","article-title":"Randomised comparative monotherapy trials of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy","volume":"346","author":"De Silva","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2004.08.002_bib10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2004.08.002_bib11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","article-title":"Effectiveness of first antiepileptic drug","volume":"42","author":"Kwan","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2004.08.002_bib12","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/01.WNL.0000059867.35547.DE","article-title":"The prevalence and treatment gap in epilepsy in China: an ILAE\/IBE\/WHO study","volume":"60","author":"Wang","year":"2003","journal-title":"Neurology"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505004002367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505004002367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T01:56:00Z","timestamp":1549158960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505004002367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S1525505004002367"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2004.08.002","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}